The AMA issued separate codes for subfascial and subcutaneous implantation of a tibial neuromodulation device.
|Videos|June 1, 2022
Shirley Lee shares her hopes for the future of chronic condition care
Author(s)Urology Times staff
Advertisement
In this video, Shirley Lee, CRNP-FNP, MPH, discusses her hopes for the future of the treatment of patients with chronic conditions. Lee is director of a patient navigation program and a nurse practitioner for the Greater Los Angeles Division of Genesis Healthcare Partners and Vice President of Clinical Strategy for Preveta.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Urology Times
1
John Sfakianos, MD, on integrating ctDNA into bladder cancer trials
2
AMA issues Category I CPT codes for implantable tibial neuromodulation in UUI
3
FDA updates in urology: September 2026
4
Enzalutamide plus salvage radiotherapy associated with improved PFS in high-risk BCR
5